Career Enhancement Program (CEP)
Career Enhancement Program (CEP)
批准号:
10439629
负责人:
Matthew J Walter
金额:
$7.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-03 至 2024-06-30
关键词:
Applications GrantsAwardBasic ScienceBiologyBiometryClinicalClinical InvestigatorClinical Trials DesignCollaborationsDevelopment PlansDiagnosisDisabled PersonsDisciplineEarly DiagnosisEducational StatusEthicsEtiologyFacultyFeedbackFinancial SupportFosteringFundingGenomeGoalsGrantGrant ReviewIndividualInstitutesInstitutionLaboratoriesLeadershipMentorsMinorityMinority RecruitmentOutcomePatient CarePatientsPopulation SciencesPreventionProfessional CompetenceProgram ReviewsResearchResearch PersonnelResearch TrainingScienceScientistSpecialized Program of Research ExcellenceStudentsTrainingTranslational ResearchUniversitiesVisitWagesWashingtonWomanWorkcareercareer developmentleukemiamultidisciplinaryoutreachpatient orientedpeerprogramsrecruitresearch and developmentskill acquisition
中文摘要
项目总结
白血病孢子职业提升计划(CEP)的目标是招募和支持新的
转化性白血病研究领域的独立调查人员。为了实现这一目标,CEP
该计划将提供资金支持、教学培训和指导研究培训。CEP将利用
机构优势从不同学科招聘基础科学家和临床研究人员以促进
多学科翻译研究,并将扩大目前通过征聘促进多样性的努力
妇女、少数族裔和残疾教职员工。针对以下具体目标提出:1.招募和支持
转化性白血病研究领域的新研究人员。每年承诺的资金总额为30万美元
以支持CEP和DRP的组合。我们将每年为CEP获奖者提供6万美元的资金。获奖者
要么是刚刚开始他们的研究生涯的初级教员,要么是
过渡到转化性白血病研究领域。2.为初级教员提供培训和指导
在转化性白血病研究中。CEP奖获得者将由一名高级基础科学和临床导师指导。
除了有指导的研究培训外,CEP还将与新的研究人员合作,打造个性化的职业生涯
发展计划,可结合授课课程、病人护理和为其量身定做的职业技能
个人目标。3.促进孢子间的协作。我们与我们的国家建立了教育交流
同辈孢子机构为CEP获奖者提供机会介绍他们的研究并与
4.促进妇女、少数族裔和残疾人的参与
白血病研究方面的研究人员。Cherilynn Shadding博士,McDonnell基因组外联主任
华盛顿大学研究所将协助招聘、培训和留住妇女、少数民族和
各级培训白血病研究方面的残障研究人员。
英文摘要
PROJECT SUMMARY
The goal of the Leukemia SPORE Career Enhancement Program (CEP) is to recruit and support new
independent investigators in the field of translational leukemia research. To accomplish this objective, the CEP
program will provide financial support, didactic training and mentored research training. The CEP will leverage
Institutional strengths to recruit basic scientists and clinical investigators from varied disciplines to promote
multidisciplinary translational research and will extend current efforts to promote diversity through the recruitment
of women, minority and disabled faculty. To the following specific aims are proposed: 1. To recruit and support
new investigators in the field of translational leukemia research. A total of $300,000 has been committed annually
to support the combined CEP and DRP. We will fund CEP awardees annually at $60,000 per year. The awardees
will either be junior faculty who are just beginning their research careers, or established researchers who are
transitioning into the field of translational leukemia research. 2. To provide training and mentoring to junior faculty
in translational leukemia research. CEP awardees will be mentored by a senior basic science and clinical mentor.
In addition to mentored research training, CEP will work with new investigators to craft an individualized career
development plan which may combine didactic coursework, patient care, and career skills tailored to their
individual goals. 3. To foster inter-SPORE collaborations. We have established educational exchanges with our
peer SPORE institutions to provide CEP awardees the opportunity to present their research and meet with the
leadership at a peer Leukemia SPORE Institution 4. To promote participation of women, minorities, and disabled
investigators in leukemia research. Dr. Cherilynn Shadding, Director of Outreach for the McDonnell Genome
Institute at Washington University will assist with the recruitment, training, and retention of women, minority, and
disabled investigators in leukemia research at all levels of training.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
-
批准号:10194402
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2013
-
负责人:Matthew J Walter
-
依托单位:
Career Enhancement Program (CEP)
-
批准号:10194406
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2013
-
负责人:Matthew J Walter
-
依托单位:
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
-
批准号:10439624
-
项目类别:
-
资助金额:$32.78万
-
财政年份:2013
-
负责人:Matthew J Walter
-
依托单位:
Career Enhancement Program (CEP)
-
批准号:10931081
-
项目类别:
-
资助金额:$4.29万
-
财政年份:2013
-
负责人:Matthew J Walter
-
依托单位:
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
-
批准号:10931078
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2013
-
负责人:Matthew J Walter
-
依托单位:
GENETICS OF MYELODYSPLASTIC SYNDROMES
-
批准号:8841404
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2011
-
负责人:Matthew J Walter
-
依托单位:
GENETICS OF MYELODYSPLASTIC SYNDROMES
-
批准号:8160381
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:Matthew J Walter
-
依托单位:
GENETICS OF MYELODYSPLASTIC SYNDROMES
-
批准号:8308383
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2011
-
负责人:Matthew J Walter
-
依托单位:
GENETICS OF MYELODYSPLASTIC SYNDROMES
-
批准号:8658143
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2011
-
负责人:Matthew J Walter
-
依托单位:
GENETICS OF MYELODYSPLASTIC SYNDROMES
-
批准号:8465898
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2011
-
负责人:Matthew J Walter
-
依托单位:
Genetic Progression Events in Murine APL
-
批准号:7097999
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2005
-
负责人:Matthew J Walter
-
依托单位:
Genetic Progression Events in Murine APL
-
批准号:6873177
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2005
-
负责人:Matthew J Walter
-
依托单位:
Genetic Progression Events in Murine APL
-
批准号:7458730
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2005
-
负责人:Matthew J Walter
-
依托单位:
Genetic Progression Events in Murine APL
-
批准号:7663796
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2005
-
负责人:Matthew J Walter
-
依托单位:
Genetic Progression Events in Murine APL
-
批准号:7263984
-
项目类别:
-
资助金额:$11.68万
-
财政年份:2005
-
负责人:Matthew J Walter
-
依托单位:
Project 3 - Genomics of Secondary AML Progression.
-
批准号:10311210
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2003
-
负责人:Matthew J Walter
-
依托单位:
Project 3 - Genomics of Secondary AML Progression.
-
批准号:10541170
-
项目类别:
-
资助金额:$42.97万
-
财政年份:2003
-
负责人:Matthew J Walter
-
依托单位:
Career Enhancement Program (CEP)
-
批准号:9756328
-
项目类别:
-
资助金额:$7.09万
-
财政年份:--
-
负责人:Matthew J Walter
-
依托单位:
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
-
批准号:9756323
-
项目类别:
-
资助金额:$31.18万
-
财政年份:--
-
负责人:Matthew J Walter
-
依托单位:
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
-
批准号:9764653
-
项目类别:
-
资助金额:$0.66万
-
财政年份:--
-
负责人:Matthew J Walter
-
依托单位:
海外基金